Turn Therapeutics Inc. 8-K

What Happened
Turn Therapeutics Inc. (TTRX) filed a Current Report on Form 8-K on March 31, 2026 to announce its financial and operating results for the year ended December 31, 2025. The company furnished a press release with those results as Exhibit 99.1 to the 8-K.

Key Details

• The 8-K was filed and the press release was issued on March 31, 2026.
• The results cover the fiscal year ended December 31, 2025.
• The press release announcing the results is furnished as Exhibit 99.1 to the Form 8-K.

Why It Matters
This filing delivers Turn Therapeutics’ latest reported financial performance and operating update for 2025 — essential information for shareholders and potential investors. The 8-K itself does not include the detailed figures in-line; investors should read the furnished press release (Exhibit 99.1) and the company’s subsequent SEC filings for full revenue, expense, cash position and management commentary. The announcement can affect near-term investor sentiment and should be reviewed alongside other public disclosures.